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Few studies have assessed the presentation, management, and outcomes of sepsis in low-
income countries (LICs). We sought to characterize these aspects of sepsis and to assess
mortality predictors in sepsis in two referral hospitals in Rwanda.
Materials and methods
This was a retrospective cohort study in two public academic referral hospitals in Rwanda.
Data was abstracted from paper medical records of adult patients who met our criteria for
sepsis.
Results
Of the 181 subjects who met eligibility criteria, 111 (61.3%) met our criteria for sepsis without
shock and 70 (38.7%) met our criteria for septic shock. Thirty-five subjects (19.3%) were
known to be HIV positive. The vast majority of septic patients (92.7%) received intravenous
fluid therapy (median = 1.0 L within 8 hours), and 94.0% received antimicrobials. Vasopres-
sors were administered to 32.0% of the cohort and 46.4% received mechanical ventilation.
In-hospital mortality for all patients with sepsis was 51.4%, and it was 82.9% for those with
septic shock. Baseline characteristic mortality predictors were respiratory rate, Glasgow
Coma Scale score, and known HIV seropositivity.
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Conclusions
Septic patients in two public tertiary referral hospitals in Rwanda are young (median age =
40, IQR = 29, 59) and experience high rates of mortality. Predictors of mortality included
baseline clinical characteristics and HIV seropositivity status. The majority of subjects
were treated with intravenous fluids and antimicrobials. Further work is needed to under-
stand clinical and management factors that may help improve mortality in septic patients in
LICs.
Introduction
Sepsis is a dysregulated host response to infection that results in life-threatening organ dys-
function [1]. Based on data from the Global Burden of Diseases, Injuries, and Risk Factors
Study (GBD) 2017, an estimated 48.9 million people worldwide experienced sepsis in 2017,
with 11.0 million deaths [2]. This burden is particularly high in low-income countries (LICs),
with an estimated 16.7 million cases of sepsis occurring annually in sub-Saharan Africa [2]. A
meta-analysis of studies in sub-Saharan Africa demonstrated a sepsis mortality rate of 19%
and a severe sepsis mortality rate of 39% [3]. In Rwanda, the mortality in two intensive care
units was shown to be 64.4% for sepsis and 82.1% for septic shock [4].
Although these data demonstrate a high incidence and mortality from sepsis in LICs, few
studies on sepsis presentation, management, outcomes, and predictors of mortality in LICs
have been reported. In a study assessing critically ill patients with suspected infection in a pub-
lic tertiary referral center in Kenya, the majority (65.1%) were suffering from respiratory infec-
tions and the most common comorbidity was diabetes mellitus (27.3%) [5]. In a survey of
critical care providers at a large tertiary center in Kenya, respondents indicated the most com-
mon sources of infection in sepsis were respiratory and intra-abdominal, the most frequently
used antibiotics were ceftriaxone and metronidazole, and 43% of respondents ordered blood
cultures on suspicion of sepsis regularly [6]. In a private hospital in rural Uganda, a study in 20
adults and 31 children with sepsis found that the most common comorbidity in adults was
HIV (30%); greater than 80% of patients received an antibiotic; and half of all patients with an
elevated lactate received intravenous fluid resuscitation [7]. In a referral hospital in the capital
city of Haiti, the most common sources of infection in patients with sepsis were lung and
intra-abdominal [8]. Management at this facility consisted of intravenous fluid resuscitation in
80% of patients with severe sepsis, and 54.6% of patients with severe sepsis received antimicro-
bials within 24 hours, with the most commonly used antimicrobials being ceftriaxone and
chloroquine.
Mortality from sepsis in most of these observational studies at large referral centers ranged
from 20.4% to 24.2%, yet mortality in the study at the rural hospital in Uganda was only 3.9%
[5–8]. The study in Haiti found encephalopathy, supplemental oxygen therapy, and stool
microscopy to be predictors of mortality among septic patients [8]. Another study in Uganda
found Glasgow Coma Scale (GCS), Karnofsky Performance Scale (KPS), tachypnea, thrombo-
cytopenia, and leukocytosis to be mortality predictors [9].
The optimal treatment of sepsis in low-income countries is unknown. The only randomized
controlled trial of sepsis resuscitation in adults in Africa demonstrated harm with fluid resusci-
tation similar to that considered standard of care in HICs [10]. This may be related to late pre-
sentation, underlying infection types that differ from those in HICs, and lack of access to
mechanical ventilation after resuscitation [10–12].
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We aimed to evaluate the presentation, management, outcomes, and predictors of mortality
from sepsis through a retrospective cohort study of patients admitted to two of the three public
tertiary hospitals in Rwanda.
Materials and methods
Study setting and population
The University Teaching Hospital of Kigali (CHUK) is a public academic tertiary referral hos-
pital in Rwanda’s capital. With approximately 565 total beds, primary facilities at the time of
this study include a three-level emergency department, inpatient internal medicine, surgery,
pediatrics, obstetrics and gynecology wards, a seven-bed intensive care unit (ICU), and a four-
bed high-dependency (step-down) unit.
The University Teaching Hospital of Butare (CHUB) is a public academic referral hospital
in the Southern Province of Rwanda. With approximately 490 beds, primary facilities at the
time of this study included an emergency department, internal medicine, surgery, pediatrics,
and obstetrics and gynecology inpatient wards, and a five-bed ICU.
Study oversight
The University of Rwanda Institutional Review Board, the Ethics Committee at CHUK, and
the Research Ethics Committee at CHUB approved the study. Individual subject consent was
waived by the University of Rwanda Institutional Review Board due to determination of mini-
mal level of risk. Data analysis was approved by the Virginia Commonwealth University Insti-
tutional Review Board.
Definitions
Sepsis was defined as suspected or confirmed infection plus two or more of the three quick
Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) criteria: respiratory rate� 22,
systolic blood pressure� 100, and Glasgow Coma Scale score < 15 [1]. The SOFA-based Sep-
sis-3 definition for sepsis is not feasible as a definition in this setting, given its requirement for
multiple lab values that are not routinely collected in these hospitals. While the qSOFA score
was developed as a screening tool for patients who might have poor outcomes, it also reflects
signs of inflammation indicative of the dysregulated immune response that defines sepsis [1].
We therefore used qSOFA in our definition of sepsis in this study. Septic shock was defined as
sepsis plus either vasopressor support or mean arterial pressure (MAP)� 60 [13]. While
serum lactate is included in current definitions of septic shock, it is rarely collected in this set-
ting and thus could not be used. Vital signs on meeting sepsis criteria are defined as the first
set of vital signs that met two or more of the qSOFA criteria while there was suspected or con-
firmed infection documented, or the set of vital signs most proximal to when clinician deter-
mination of sepsis was documented. Laboratory values associated with sepsis (white blood cell
count, platelet count, creatinine, and bilirubin) were captured if drawn within 24 hours of the
time when the patient met sepsis criteria, and the laboratory values most proximal to the time
of sepsis were recorded.
Acute respiratory distress syndrome was defined by clinician documentation, as blood gas
analysis for determination of PaO2 is not available at CHUB, and is performed infrequently at
CHUK. Acute kidney injury was defined by either clinician documentation or by creatinine
values in the Kidney Disease: Improving Global Outcomes (KDIGO) criteria: increase in
serum creatinine by� 0.3 mg/dl within 48 hours or increase in serum creatinine to� 1.5
times baseline [14]. Coagulopathy was defined as activated partial thromboplastin time (aPPT)
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> 40 seconds, or international normalized ratio (INR) >1.2, or elevated d-dimer, based on
local reference ranges. Acute liver injury was defined as INR� 2.0, ALT�10 times the upper
limit of normal and bilirubin�3.0 mg/dL, and acute liver failure was defined as development
of severe acute liver injury with encephalopathy and impaired synthetic function (INR of
�1.5) in a patient without cirrhosis or preexisting liver disease or by clinician’s documentation
[15, 16]. Myocardial infarction was defined by either clinician documentation or as elevated
creatine kinase-MB (CK-MB) or elevated troponin (elevations defined based on local reference
ranges). Rural and urban districts were defined according to designations from the Rwanda
Ministry of Finance and Economic Planning [17].
Data collection and quality assurance
At CHUK, the study team screened a paper admission and discharge central logbook in which
patient medical record number and final diagnosis or diagnoses are recorded. We screened
logbook entries with discharge dates between January 1, 2017 and December 31, 2017, and
those with a final diagnosis of sepsis, septic shock, or any infection underwent chart review in
the medical archives. Once patients met the logbook screening criteria, all paper medical rec-
ords were accessed in the archive to determine if they met clinical inclusion criteria (presence
of sepsis or septic shock as defined below plus age greater than 17 at time of presentation).
CHUB does not have a central admission and discharge logbook. Potential subjects were
screened by accessing the central archive and reviewing medical records from the paper medi-
cal records partitioned by discharging service and year. From the ICU and from the internal
medicine and surgical wards with discharge dates in 2017, we searched for documentation of
sepsis, septic shock, or any documented infection in the paper medical records and subse-
quently determined if the patient met inclusion criteria. We screened all patients discharged
from the ICU and a convenience sample of patients discharged from the internal medicine
and surgery wards.
A study team comprised of students, residents, and faculty physicians conducted and super-
vised the data abstraction. All data abstracted was retrospective: vital sign and urine output
data in the paper medical record was entered during the time of patient care by either the
patient’s nurses or physicians, and the remaining data in the paper medical record was entered
by the patient’s physicians. During medical record review, data was entered directly into the
web-based Research Electronic Data Capture (REDcap) tool (Nashville, Tennessee) using per-
sonal computers (PCs). The initial 60 charts that met study criteria were reviewed in REDCap
by DH and MD for quality assurance purposes, and demonstrated some inconsistencies in
data collection. The data from these medical records were thus abstracted by DH and MD.
Subsequently, the study team had further training through didactic sessions, interactive case
studies, and hands-on side-by-side chart review. A standard operating procedure (SOP) docu-
ment was provided to all data collectors prior to resumption of chart review. For the 121 medi-
cal records abstracted by the student data collectors, quality assurance was performed by a
resident physician. An audit of 12% of these medical records randomly selected was also per-
formed by WM to ensure consistency with data entered into REDCap.
Statistical analysis
In-hospital mortality was the primary outcome of interest, as it is an objective outcome crite-
rion for which data was readily available. Continuous data are summarized using medians and
interquartile ranges unless otherwise specified. Demographic characteristics, baseline clinical
features, and management variables were compared for in-hospital survivors and non-survi-
vors. Continuous data with normal distributions were compared in univariate analysis for
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model building using equal variance or unequal variance two sample independent t-tests with
equality of variances assessed using the Brown-Forsythe test. Comparisons for nonparametric
continuous data were made using the Wilcoxon rank-sum test. Categorical variables are sum-
marized with proportions, and differences were compared in univariate analysis for model
building using χ2 test or Fisher’s exact test. Significance was determined if p-value was less
than 0.05.
Multivariable logistic regression of baseline variables was performed to assess for predictors
of in-hospital mortality, and predictive variables from this model were used to control for
severity of illness when performing an exploratory multivariable logistic regression analysis of
potential relationships between management variables and in-hospital mortality. All signifi-
cant univariates were assessed for interactions with age, sex, hospital, province of residence,
and residence in a rural district. Interactions between these variables were included in model
selection as potential predictors if p-values were less than 0.05. For both the baseline variable
model and management variable models, univariates with p-values less than 0.05 and those
with probable clinical significance were selected to be included in a forward stepwise selection
methodology, with the p-value threshold set at 0.10. The automated forward stepwise selection
method was then performed. Given the large number of significant covariates after perfor-
mance of forward stepwise selection, those in the model with p-values greater than 0.90 were
removed and the logistic regression was performed without these covariates to create the final
model.
Multicollinearity was assessed using correlation coefficients and through assessment of
parameter sign switching (negative to positive or vice versa), and potential covariates with
r> 0.85 and/or those with reversal of sign were assessed and the most clinically relevant covari-
ate was retained in the analysis. We report adjusted odds ratios and 95% confidence intervals of
the adjusted odds ratios, likelihood ratio chi square statistics, and p-values for both models. We
also performed and report for both models the fit statistics of area under the receiver operating
characteristic curve, Hosmer-Lemeshow statistic and p-value, Brier score, and Nagelkerke
pseudo R2. Statistical analysis was performed with R version 4.0.2 and JMP Pro version 15.
Results
Demographic and baseline characteristics
A total of 181 charts met inclusion criteria (100 at CHUK and 81 at CHUB) and were
reviewed. Nearly three quarters of our sample were female (72.4%), and the median age was 40
(IQR = 29, 59) (Table 1). Nearly half (48.9%) of the subjects resided in a rural district. The
majority (89.0%) of patients were transferred from a district hospital or health center. Of the
113 patients transferred from another health center, we had data on length of stay at the out-
side facility for 32/113 (28.3%). For those, the median length of stay at these facilities was 2.0
days (IQR = 1.0, 5.5).
One hundred eight subjects (59.7%) met criteria for sepsis at time of hospital admission
and 73 met inclusion criteria later in the hospital course. The median time from hospital pre-
sentation to meeting criteria for sepsis was 0 days (IQR 0, 1.3). Vital signs were recorded con-
sistently with the exception of respiratory rate and temperature (38.1% and 32.6% of values
were missing, respectively) (S1 Table). At time of meeting criteria for sepsis, median heart rate
was 112 beats per minute, respiratory rate was 24 breaths per minute, systolic blood pressure
was 96 mmHg, temperature was 37.1˚C, SpO2 was 95%, and median GCS was 15 (IQR 11, 15)
(Table 1). Median white blood cell count, platelet count, and creatinine were within normal
limits. Known HIV positive patients represented 19.3% of the sample; 6.1% of the sample had
known prior hypertension; 6.1% had diabetes mellitus. Other comorbidities (Hepatitis B or C,
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Table 1. Demographic and baseline characteristics.
Number of patients with
data
Full cohort Survivors Non-survivors
n (% of total cohort) n (%) or median
[IQR]
n (%) or median
[IQR]




Male 50 (27.6) 13 (26.0) 37 (74.0)
Female 131 (72.4) 75 (57.3) 56 (42.7)
Age 178 (98.3) 40 [29,59] 36 [26,57] 44 [31,61]
Province of residence 179 (98.9)
Southern 79 (44.1) 25 (31.6) 53 (58.2)
Kigali 63 (35.2) 46 (73.0) 17 (18.9)
Western 17 (9.5) 6 (35.3) 11 (64.7)
Eastern 11 (6.1) 5 (45.5) 6 (54.5)
Northern 9 (5.0) 5 (55.6) 4 (44.4)
Reside in urban vs rural district 178 (98.3)
Urban 91 (51.1) 56 (61.5) 35 (38.5)
Rural 87 (48.9) 30 (34.5) 57 (65.5)
Presenting characteristics
Where patient presented from 127 (70.2)
District hospital 113 (89.0) 36 (31.9) 77 (68.1)
Home or work 6 (4.7) 4 (66.7) 2 (33.3)
Other 9 (7.1) 7 (77.8) 2 (22.2)
Length of stay at district hospital 32 (17.7) 2.0 [1.0,5.5] 2.0 [1.0,5.5] 2.0 [1.0,6.5]
Hospital presented to 181 (100.0)
CHUK 100 (55.2) 65 (65.0) 35 (35.0)
CHUB 81 (44.8) 23 (28.4) 58 (71.6)
Met sepsis criteria at time of hospital admission 181 (100.0) 108 (59.7) 47 (43.5) 61 (56.5)
Time from presentation to meeting sepsis criteria 166 (89.0) 0.0 [0.0,1.25] 0.39 [0.0,1.3] 0.0 [0.0,1.25]
Vital signs on meeting sepsis criteria
Heart rate in beats per minute 175 (96.7) 112 [94,125] 106 [92,120] 120 [104,129]
Systolic blood pressure in mmHg 176 (97.2) 96 [89,118] 96 [91,110] 97 [86,120]
Mean arterial pressure in mmHg 174 (96.1) 71 [64.5,85] 71 [66,80] 73 [61,89]
Respiratory rate in breaths per minute 112 (61.9) 24 [21,28] 23 [20,26] 25 [22,32]
Temperature in degrees Celsius 122 (67.4) 37.1 [36.4,38.0] 37.0 [36.3,38.2] 37.1 [36.5,38.0]
Oxygen saturation 151 (83.4) 95 [92,98] 96 [94,98] 95 [91,98]
Glasgow Coma Scale score 171 (94.5) 15 [11,15] 15 [14,15] 14 [9,15]
Laboratory results within 24 hours of meeting sepsis
criteria
White blood cells g/L 152 (84.0) 7.9 [3.9,13.0] 6.6 [3.9.10.7] 8.5 [4.3,13.9]
Platelets g/L 147 (81.2) 171 [68,308] 187 [110,349] 137 [48,296]
Creatinine 127 (70.2) 0.8 [0.5,1.52] 0.85 [0.52,1.37] 0.79 [0.50,1.67]
Positive malaria blood smear 95 (52.5) 21 (22.1) 13 (61.9) 8 (38.1)
Positive Mycobacterium tuberculosis assay 35 (19.3) 5 (14.3) 3 (60.0) 2 (40.0)
Comorbidities 181 (100.0)
HIV 35 (19.3) 24 (68.8) 11 (31.4)
Any other comorbiditya 29 (16.0) 13 (44.8) 16 (55.2)
Source of infection (discharge diagnosis)b 181 (100.0)
Intra-abdominal 67 (37.0) 22 (32.8) 45 (67.2)
(Continued)
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malignancy, and chronic kidney, liver, heart, or lung disease) were seen in the subjects at rates
less than 5%.
The most common source of infection documented at discharge was intra-abdominal
(37.0%) followed by pulmonary (32.6%) (Table 1). Of the 95 patients who received a malaria
blood smear, 21 (22.1%; 11.6% of the total cohort) were positive for Plasmodium species. Five
patients (2.8% of the total cohort) tested positive for Mycobacterium tuberculosis either by
acid-fast bacilli smear or nucleic acid amplification test. Of the 55 blood cultures obtained, 9
(16.4%) were positive. Sensitivities were available for four of these samples, and antimicrobial
resistance was present in three samples (S2 Table). Antimicrobial resistance in urine cultures
(n = 4) was present in all samples (S3 Table).
Diagnostics and management. Sepsis or septic shock was listed as a diagnosis in the med-
ical record in two-thirds of cases (Table 2). Septic shock criteria were met by 70 (38.7%) sub-
jects. Patients with sepsis or septic shock were most frequently managed in the internal
medicine ward. The majority of patients (n = 95, 52.5%) had performance of a malaria blood
smear recorded (S4 Table). Blood cultures were drawn in 55 (30.4%) of patients and 36
(19.9%) had a urine culture performed. Twenty-six patients (14.4%) were assessed for tubercu-
losis by nucleic acid amplification test and 9 (5.0%) were assessed by acid-fast bacilli smear (S4
Table). Ultrasound of any internal organ was performed in 45.3% of patients and 34.8% of
patients received a chest radiograph (S4 Table).
The vast majority of patients (92.7%) received intravenous fluid resuscitation within 8
hours and 96.8% received fluid resuscitation within 24 hours (Table 2). The median volume of
intravenous fluid administered in the first 8 hours after meeting sepsis criteria was 1.0 L
(IQR = 0.5, 2.0 L), and in the first 24 hours the median intravenous fluid received was 2.0 L
(IQR = 1.0, 4.0 L). Nearly all patients (94.0%) received at least one antimicrobial, and the most
frequently administered antimicrobials were ceftriaxone and metronidazole (S5 Table). Anti-
microbials with broader spectrums of activity were frequently added later in the hospital
course (S2 Table). Exploratory laparotomy was performed on 23.8% of subjects (Table 2).
Vasopressors were administered in 58 patients (32.0%) and the most frequently adminis-
tered vasopressor was epinephrine followed by dopamine (Table 2). A total of 46.4% of
patients with sepsis received mechanical ventilation. The median duration of vasopressors and
mechanical ventilation was 0.7 days (IQR 0.3, 2.1) and 2.4 days (IQR 0.8, 7.2), respectively.
Glucocorticoids were administered in 7.7% of cases, and 9 patients (5.0%) underwent central
venous catheter placement.
Table 1. (Continued)
Number of patients with
data
Full cohort Survivors Non-survivors
n (% of total cohort) n (%) or median
[IQR]
n (%) or median
[IQR]
n (%) or median
[IQR]
Pulmonary 59 (32.6) 33 (55.9) 26 (44.1)
Skin/wound 21 (11.6) 12 (57.1) 9 (42.9)
Central nervous system 20 (11.0) 5 (25.0) 15 (75.0)
Urine 8 (4.4) 5 (62.5) 3 (37.5)
Bacteremia with unknown source 1 (0.6) 1 (100) 0 (0)
Other 21 (11.6) 14 (66.7) 7 (33.3)
aOther comorbidities include diabetes mellitus (n = 11, 6.1%), hypertension (n = 11, 6.1%), hepatitis B or C (n = 5, 2.8%), cancer (n = 3, 1.7%), chronic kidney disease
(n = 3, 1.7%), chronic liver disease (n = 3, 1.7%), chronic lung disease (n = 2, 1.1%), and chronic heart disease (n = 1 0.6%).
bThis is not a mutually exclusive category. One patient may have multiple sources of infection.
https://doi.org/10.1371/journal.pone.0251321.t001
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Outcomes
Acute kidney injury was the most common complication (19.3%), followed by acute respira-
tory distress syndrome (9.9%) (Table 3). The median length of stay in the ICU was 2.3 days
and the median length of stay in the internal medicine and surgery wards were 9.4 days and
6.0 days, respectively. The overall median length of stay in the referral hospital was 9.5 days.
Table 2. Management.
Number of patients with data Full cohort Survivors Non-survivors
n (% of total cohort) n (%) or median [IQR] n (%) or median [IQR] n (%) or median [IQR]
Sepsis named in the patient’s chart 180 (99.4) 120 (66.7) 43 (35.8) 77 (64.2)
Primary location of sepsis management 179 (98.9)
Medicine ward 77 (43.0) 58 (75.3) 19 (20.7)
ICU 57 (31.8) 12 (21.1) 45 (48.9)
A&E 27 (15.1) 9 (33.3) 18 (19.6)
Surgery Ward 14 (7.8) 8 (57.1) 6 (42.9)
OB/GYN Ward 4 (2.2) 0 (0) 4 (100)
Intravenous fluid resuscitation 123 (68.0)
Volume (L) received in first 8 hours 1.0 [0.5,2.0] 1.0 [0.5,2.0] 2.0 [1.0,2.7]
Volume (L) received in first 24 hours 2.0 [1.0,4.0] 1.5 [1.0,2.8] 2.5 [1.5,4.6]
Antimicrobialsa 181 (100.0)
At least one antimicrobial administered 170 (93.9) 84 (49.4) 86 (50.6)
Ceftriaxone 108 (59.7) 52 (48.1) 56 (51.9)
Metronidazole 76 (42.0) 24 (31.6) 52 (68.4)
Cefotaxime 15 (8.3) 2 (13.3) 13 (86.7)
Artesunate 13 (7.2) 9 (169.2) 4 (30.8)
Doxycycline 10 (5.5) 7 (70.0) 3 (30.0)
Glucocorticoid therapy 181 (100.0) 14 (7.7) 3 (21.4) 11 (78.6)
Vasopressors 181 (100.0)
At least one vasopressor administered 58 (32.0) 4 (6.9) 54 (93.1)
Vasopressors administeredb
Epinephrine 38 (21.0) 4 (10.5) 34 (89.5)
Dopamine 23 (12.7) 0 (0) 23 (100)
Norepinephrine 13 (7.2) 0 (0) 13 (100)
Mechanical ventilation 181 (100.0)
Received mechanical ventilation 84 (46.4) 14 (16.7) 70 (83.3)
Duration of vasopressors and mechanical ventilation
Duration of vasopressors in days 76 (42.0) 0.7 [0.3,2.1] - -
Duration of mechanical ventilation in days 69 (38.1) 2.4 [0.8,7.2] 3.0 [0.8,16.8] 2.0 [0.8,6.9]
Procedures performed 181 (100.0)
Intubation 80 (44.2) 12 (15.0) 68 (85.0)
Exploratory laparotomy 43 (23.8) 9 (20.9) 34 (79.1)
Abscess drainage 9 (5.0) 2 (22.2) 7 (77.8)
Central line 9 (5.0) 1 (11.1) 8 (88.9)
Wound debridement 9 (5.0) 3 (33.3) 6 (66.7)
Bronchoscopy 3 (1.7) 2 (66.7) 1 (33.3)
Other 12 (6.6)
afor full list, see S5 Table.
bmultiple vasopressors can be administered to the same patient
https://doi.org/10.1371/journal.pone.0251321.t002
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The in-hospital mortality rate for sepsis or septic shock in this study was 51.4%. Mortality for
septic shock was 82.9% and for sepsis without septic shock was 31.5%.
Predictors of mortality. On univariate analysis, presentation characteristics associated
with in-hospital mortality were male sex, age, province of residence, residing in a rural district,
transfer from a district hospital, presentation to CHUB, high respiratory rate when meeting
inclusion criteria, lower GCS score when meeting inclusion criteria, lower platelet count, HIV
positive status, and intra-abdominal or central nervous system source of infection. There were
no significant interactions between assessed covariates. Baseline characteristics at the time of
meeting sepsis criteria with statistical significance that predicted mortality on multivariable
logistic regression were one breath per minute increase in respiratory rate (adjusted odds ratio
(aOR) = 1.10, 95% CI = 1.01–1.21, p-value = 0.037), one point decrease in GCS (aOR = 0.793,
95% CI = 0.621–0.968, p-value = 0.021), and known HIV+ status (aOR = 7.02, 95% CI = 1.15–
55.8, p-value = 0.034) (S6 Table). The area under the receiver operating characteristic curve for
this model was 0.861 (95% CI: 0.787–0.934). Additional fit statistics include Hosmer-Leme-
show chi-square statistic of 3.0662 (p-value = 0.930), Brier Score = 0.150, and Nagelkerke
pseudo R2 = 0.513.
Management characteristics on univariate analysis associated with higher mortality
included higher volume of fluid resuscitation in the first eight hours after sepsis presentation,
management in the intensive care unit, urine output not recorded by nursing staff, receiving
metronidazole or cefotaxime, receiving steroids, receiving vasopressor therapy, receiving
mechanical ventilation, and undergoing intubation, exploratory laparotomy, or central venous
catheter placement (Table 2). No significant interactions were found between assessed covari-
ates. Nearly all (93.1%) patients who received at least one vasopressor died and the vast major-
ity (83.3%) of those who received mechanical ventilation died. Upon controlling for age, sex,
Table 3. Outcomes.
Number of patients with data Full cohort Survivors Non-survivors
n (% of total cohort) n (%) or median [IQR] n (%) or median [IQR] n (%) or median [IQR]
Complications 181 (100.0)
Acute kidney injury 35 (19.3) 7 (20.0) 28 (80.0)
Acute respiratory distress syndrome (ARDS) 18 (9.9) 4 (22.2) 14 (77.8)
Acute liver injury or liver failure 2 (1.1) 1 (50.0) 1 (50.0)
Coagulopathy 1 (0.6) 1 (100) 0 (0)
Myocardial infarction 0 (0) 0 (0) 0 (0)
Length of stay by service in days
Emergency department 104 (57.5) 0.6 [0.2,1.1] 0.7 [0.2,1.0] 0.6 [0.2,1.3]
Medicine ward 77 (42.5) 9.4 [4.5,15.9] 10.4 [5.7,18.1] 7.6 [3.0,9.6]
Surgery ward 29 (16.0) 6.0 [1.0,21.6] 18.7 [2.0,30.4] 1.2 [0.9,12.2]
Obstetrics and gynecology ward 14 (7.7) 0.4 [0.2,6.8] 3.2 [0.3,8.3] 0.4 [0.1,4.6]
Intensive care unit 80 (44.2) 2.3 [0.3,7.0] 6.0 [1.0,23.4] 1.9 [0.5,6.7]
Length of stay at referral hospital 173 (95.6) 9.5 [4.1,19.9] 12.7 [6.9,23.8] 6.7 [1.9,11.8]
Disposition 181 (100.0)
Died 93 (51.4)
Sepsis (without shock) and died 35 (31.5)
Sepsis with shock and died 58 (82.9)
Discharge to home 73 (40.8)
Discharge to district hospital 12 (6.6)
Eloped from hospital 1 (0.6)
https://doi.org/10.1371/journal.pone.0251321.t003
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and the predictors identified in the presentation characteristics model (illness severity
indicators of respiratory rate and GCS, and known HIV+ status) the management factors with
statistical significance associated with mortality on multivariable logistic regression were
administration of vasopressors (aOR = 7.46, 95% CI = 1.69–40.2, p-value = 0.007) and
mechanical ventilation (aOR = 6.65, 95% CI = 1.04–51.6, p-value = 0.046) (S7 Table). The area
under the receiver operating characteristic curve for this model was 0.895 (95% CI: 0.829–
0.961). Additional fit statistics for this model include a Hosmer-Lemeshow chi-square statistic
of 7.943 (p-value = 0.439), Brier score = 0.127, and Nagelkerke pseudo R2 = 0.569.
Discussion
We examined presentation, management, and outcomes of sepsis and septic shock at two
tertiary referral hospitals in Rwanda. Mortality from sepsis without shock was 31.5%, and mor-
tality from septic shock was 82.9%. The most common source of infection was intra-abdomi-
nal. Intravenous fluid resuscitation and antimicrobials were administered in most cases.
Baseline characteristics at time of meeting sepsis criteria predicting mortality included respira-
tory rate, GCS score, and HIV+ status. When adjusting for these illness severity factors, man-
agement predictors of mortality were administration of vasopressors and mechanical
ventilation.
Intravenous fluid resuscitation, antimicrobial administration, and source control are key
aspects of sepsis management. In our sample, 93% received intravenous fluid resuscitation
within 8 hours and the median volume received within this time frame was 1.0 L. The evidence
for optimal standards of intravenous fluid resuscitation in sepsis in sub-Saharan Africa has
been mixed [9–12]. In the only randomized controlled trial assessing intravenous fluid resusci-
tation in adults with sepsis in sub-Saharan Africa, Andrews et al. [10] found higher mortality
in patients who received a greater volume of intravenous fluid resuscitation (3.5 L compared
to 2.0 L within the first 6 hours after presentation). The Fluid Expansion As Supportive Ther-
apy (FEAST) trial in African children revealed similar findings, as patients who received intra-
venous fluid bolus experienced higher mortality [18]. The most appropriate volume of fluid
resuscitation in patients with sepsis remains unclear.
The vast majority of our sample (94.0%) received antimicrobial therapy. The most frequent
antibiotic administered was ceftriaxone, and while we only had culture data from 8 patients in
this study, all isolates tested for ceftriaxone were resistant to it. Our findings are similar to a
2018 study of peritonitis in Rwanda, in which 95.8% of patients with infectious peritonitis
(95% meeting criteria for sepsis or severe sepsis) received antibiotics and the most frequently
prescribed antibiotics were third generation cephalosporins (90% of cases) and metronidazole
(85% of cases) [19]. Cephalosporin resistance was also high in that study as only one of seven
isolates was sensitive to ceftriaxone. High rates of cephalosporin resistance in Rwanda has
been demonstrated in several other studies as well [20–23]. Significantly more patients in our
study received antimicrobials besides ceftriaxone and metronidazole later in their hospital
course, presumably on clinical deterioration. Regarding source control, we collected data on
intra-abdominal infections, and 43 out of 67 patients (64.2%) with an intra-abdominal source
of infection underwent exploratory laparotomy.
Our findings of GCS, respiratory rate, and HIV+ status as significant baseline characteris-
tics at time of meeting sepsis criteria predicting mortality have some overlap with Moore
et al.’s [24] Universal Vital Assessment (UVA) score and Riviello et al.’s [4] Rwanda Mortality
Probability Model (R-MPM). The UVA score, developed from data from 6 countries in sub-
Saharan Africa, serves to predict mortality of patients in resource-limited settings admitted to
the hospital for any reason. In addition to our above predictors that align with the UVA score,
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the score also includes temperature, heart rate, and systolic blood pressure. The R-MPM,
based on data from patients admitted to the ICU, employs the mortality predictors of age,
suspected or confirmed infection within 24 hours of ICU admission, hypotension or shock as
a reason for ICU admission, Glasgow Coma Scale score (aligns with our findings) at ICU
admission, and heart rate at ICU admission. In another study on peritonitis in Rwanda in
which 83% of patients had sepsis or severe sepsis, Ndayizeye et al. [25] found that predictors of
mortality included unplanned reoperation, vasopressor use (aligns with our findings), abnor-
mal white blood cell count, ICU admission, and American Society of Anesthesiologist score
of� 3.
We found mechanical ventilation and administration of vasopressors to be the only man-
agement predictors of mortality. While it is possible that these management modalities do
result in worse outcomes given risks of harm with these interventions, it is more likely that the
use of mechanical ventilation or vasopressors are indicators of severity of illness that were not
captured by our three-variable model. Further study is needed.
Our study had several limitations. First, we defined sepsis as suspected or confirmed infec-
tion plus two or more of the three qSOFA criteria (respiratory rate� 22, systolic blood
pressure� 100, and Glasgow Coma Scale score < 15) [1]. The Sepsis-3 task force defined sep-
sis as “life-threatening organ dysfunction caused by a dysregulated host response to infection.”
They suggested that the definition could be operationalized as an increase in SOFA score of 2
or more points, due to infection. They further suggested that the qSOFA criteria could be used
to identify patients with a high likelihood of a poor outcome, particularly in out of hospital,
emergency department, and ward settings [1]. Both operationalizations of the conceptual defi-
nition correlated with mortality. While the increase in SOFA score of two points is more com-
monly used to operationalize the definition for research, it was not possible in our cohort
given that PaO2 and bilirubin, two key components of SOFA, are almost never available in this
setting. We therefore used the qSOFA criteria to operationalize the definition of sepsis. It is
not clear in what direction this might bias our results, but our population may be different
than other cohorts that are defined using the SOFA score. We were also unable to include lac-
tate in our definition of septic shock; again, this may mean that our cohort is somewhat differ-
ent than others that define septic shock using both blood pressure and lactate. It is not clear in
what direction this would bias our results.
Second, both our methods, as well as limitations in clinical documentation, led to a selec-
tion bias toward the inclusion of ICU patients over ward patients. While we screened all
patients at CHUK discharged in 2017 for our inclusion criteria, at CHUB we screened all
patients discharged in 2017 from the ICU, but only screened a portion of patients discharged
from the internal medicine and surgery wards due to our resource limitations. This results in
missing cases of sepsis at CHUB and a selection bias at CHUB toward patients discharged
from the ICU. At both hospitals, vital signs are recorded with greater consistency in the ICU
than in the wards, which may have led to additional selection bias toward ICU patients, since
vital signs are included in the inclusion criteria. Finally, our inclusion criterion of two out of
three qSOFA criteria, as opposed to one out of three criteria, may have resulted in bias toward
more critically ill patients since every one point increase in qSOFA score is associated with
higher mortality [26, 27]. We chose to use two out of three qSOFA criteria to achieve higher
specificity [28, 29]. All of these factors lead to a selection bias that favors ICU patients being
included in our study. This means that outcomes may be worse than might be expected from a
comprehensive sampling of all hospital patients with sepsis.
Third, the limitations of clinical documentation for use in research led to an undercounting
of sepsis cases, as well as missing data for the participants included. The CHUK central admis-
sion and discharge logbook lists final diagnosis or diagnoses as free text entries without
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standardization, and often with only primary diagnosis listed. It is possible that patients could
have an infection or sepsis as one of their diagnoses, but that this would not be listed in the log-
book. This may have led to fewer cases of sepsis at CHUK being captured. Indeed, previous
studies have found higher proportions of hospitalized patients with a sepsis diagnosis [7, 30,
31], suggesting our method of screening may have missed patients with sepsis. Additionally, as
this was a retrospective study, we were limited to data that was available in the medical records.
Missing data rates ranged from 0% to 85.6%. This may have led to lower detection rates of sep-
sis since the three variables in the qSOFA score used for defining sepsis here include variables
that are inconsistently recorded. This study cannot speak to the incidence or prevalence of sep-
sis at these facilities, given that our screening methods and inclusion criteria are likely to have
missed cases of sepsis.
Missing values also mean that data on the included patients is incomplete in some cases.
Laboratory values and imaging results are recorded inconsistently in physician documentation
or are available on slips of paper which may be lost. Additionally, cardiac enzymes, liver and
coagulation profiles, and arterial blood gasses are rarely ordered and thus our rates of myocar-
dial infarction, liver failure, coagulopathy, and ARDS are almost certainly lower than actual
rates. Patients may have had underlying comorbidities that were not documented in the medi-
cal record.
Fourth, we were limited in our ability to define septic shock using established criteria since
serum lactate level is rarely available in our setting, and vasopressors are not consistently avail-
able to all patients given resource constraints. We were able to define septic shock only based
on whether a vasopressor was administered, or whether a patient had hypotension. Fifth, we
were unable to determine the timing of antimicrobial administration as the precise time is
infrequently recorded.
Finally, while we attempted to control for severity of illness in the management mortality
predictors model by including baseline characteristics that predicted mortality, we found
nonetheless that receiving mechanical ventilation or vasopressor therapy remained as mortal-
ity predictors in the final model. The severity of illness scores are imperfect. The predictive
value of mechanical ventilation and vasopressor therapy likely reflect the fact that more criti-
cally ill patients require these interventions, not that these interventions themselves are a cause
of mortality.
The limitations of our study themselves suggest potential areas of quality improvement in
sepsis care: monitoring and documentation of vital signs, as well as recognition of sepsis.
Respiratory rate was missing in 38% of charts, and temperature in 33%. One-third of the sub-
jects we identified as having sepsis did not have a sepsis diagnosis named in the medical
record.
Future studies would greatly benefit from prospective data collection to document other
aspects of care that may not have been recorded, to determine precise antimicrobial adminis-
tration time and antimicrobial resistance patterns, and to assess potential delays in access to
care and delays in operative procedures for source control, as these have been shown to be
high and likely predict poor outcomes [32].
Conclusion
Sepsis and septic shock remain understudied in sub-Saharan Africa. Sepsis and septic shock
mortality were high in our sample of patients at two tertiary referral hospitals. The vast major-
ity of patients received therapy with antimicrobials and intravenous fluid resuscitation. Base-
line characteristics that predicted mortality in our sample were GCS, respiratory rate, and HIV
+ status. Future work should focus on optimal targets for intravenous fluid resuscitation,
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antimicrobial resistance and timing of administration, and appropriate use of vasopressors
and mechanical ventilation.
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